Result: – $2,500,000
Product Liability/Pharmaceutical Negligence
This was a pre-filing settlement of a case involving injuries sustained by a 56-year-old woman taking the diet drugs Phen-Fen and Redux. The plaintiff began having severe respiratory difficulty within six months of taking the diet drugs and was diagnosed with Primary Pulmonary Hypertension (PPH). PPH a life threatening condition causing injury to the heart and lungs that required her to undergo treatment with prostacyclin (Flolan), a medication that is administered continuously through a surgically implanted IV site. The woman will be Floan dependent for the rest of her life. The PPH is a condition that was excluded from the diet drug class action suits. The PPH has rendered the Perey Law Group client disabled and forced her to retire from the records division of a local police department where she was employed for ten years. If the Floan is unsuccessful in controlling the respiratory distress she experiences, the only other form of treatment available is a heart-lung transplant. The case was settled before trial.